Other
Neoplasm by Site
CI-CAN-00000003Explore in graph →
Non-malignant20,474 active trials253 approved drugs3,567 evidence items
Loading cancer entity…
Other
CI-CAN-00000003Explore in graph →
Genomics
477 cohorts mapped to this entity or its descendants. Each frequency is affected / profiled within one cohort; cohorts are shown separately because case selection, sequencing depth and definitions differ. By default the cohort with the most cases profiled is shown.
29 cases with simple somatic mutation data · 29 cases total · 2026-02-10 · mapped to Pancreatic Adenocarcinoma EXACT_IDENTIFIER
| # | Gene | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Source |
|---|---|---|---|---|---|---|
| 1 | KRAS | Ssm | 18 |
Cohorts mapped to a descendant (e.g. a subtype) are included because their cases belong to this entity by definition; the mapping and its match type are shown per cohort.
| 29 |
| 62.1% |
| cbioportal |
| 2 | TP53 | Ssm | 14 | 29 | 48.3% | cbioportal |
| 8 | ZNF676 | Ssm | 3 | 16 | 18.8% | cbioportal |
| 24 | FAM86C1P | Ssm | 2 | 16 | 12.5% | cbioportal |
| 48 | PRDM5 | Ssm | 2 | 16 | 12.5% | cbioportal |
| 43 | OR4C46 | Ssm | 2 | 16 | 12.5% | cbioportal |
| 53 | SMOC1 | Ssm | 2 | 16 | 12.5% | cbioportal |
| 32 | HLA-G | Ssm | 2 | 16 | 12.5% | cbioportal |
| 40 | NOTCH2NLA | Ssm | 2 | 16 | 12.5% | cbioportal |
| 38 | NBPF12 | Ssm | 2 | 16 | 12.5% | cbioportal |
| 33 | KIF2B | Ssm | 2 | 16 | 12.5% | cbioportal |
| 20 | DAB2 | Ssm | 2 | 16 | 12.5% | cbioportal |
| 35 | MARCHF7 | Ssm | 2 | 16 | 12.5% | cbioportal |
| 52 | SDHAP1 | Ssm | 2 | 16 | 12.5% | cbioportal |
| 4 | CDK8 | Ssm | 3 | 29 | 10.3% | cbioportal |
| 6 | KMT2C | Ssm | 3 | 29 | 10.3% | cbioportal |
| 5 | CDKN2A | Ssm | 3 | 29 | 10.3% | cbioportal |
| 7 | RNF43 | Ssm | 3 | 29 | 10.3% | cbioportal |
| 3 | APC | Ssm | 3 | 29 | 10.3% | cbioportal |
| 51 | RTEL1 | Ssm | 2 | 28 | 7.1% | cbioportal |
| 9 | ALB | Ssm | 2 | 28 | 7.1% | cbioportal |
| 47 | PRDM14 | Ssm | 2 | 28 | 7.1% | cbioportal |
| 55 | USP8 | Ssm | 2 | 28 | 7.1% | cbioportal |
| 31 | HLA-C | Ssm | 2 | 28 | 7.1% | cbioportal |
| 23 | ETAA1 | Ssm | 2 | 28 | 7.1% | cbioportal |
| 21 | DNMT3B | Ssm | 2 | 29 | 6.9% | cbioportal |
| 10 | ARID2 | Ssm | 2 | 29 | 6.9% | cbioportal |
| 11 | ASXL1 | Ssm | 2 | 29 | 6.9% | cbioportal |
| 12 | AXIN1 | Ssm | 2 | 29 | 6.9% | cbioportal |
| 13 | BAP1 | Ssm | 2 | 29 | 6.9% | cbioportal |
Data updated 21 days agoSource updated 2026-02-10